Literature DB >> 2450350

Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19.

J A Ledbetter1, P S Rabinovitch, C H June, C W Song, E A Clark, F M Uckun.   

Abstract

Increases in cytoplasmic free calcium ([Ca2+]i) can be induced in resting B cells either by a low molecular weight (12-kDa) B-cell growth factor (LMW-BCGF) or by crosslinking the B-cell antigen CD19 with monoclonal antibody (mAb). LMW-BCGF causes a slow [Ca2+]i increase in peripheral blood and tonsillar B cells but has no effect on [Ca2+]i in resting T cells. B-cell [Ca2+]i responses mediated by anti-surface immunoglobulin (sIg) or anti-CD19 are potentiated by LMW-BCGF, but anti-sIg and anti-CD19 do not show additive [Ca2+]i responses. LMW-BCGF- and anti-CD19-induced [Ca2+]i signals are similar to the sIgM or sIgD-mediated signals in that they are inhibited by prior treatment with phorbol 12-myristate 13-acetate. However, LMW-BCGF- and CD19-mediated signals do not depend on the expression of sIg, since they were also observed on sIg-B-cell precursor acute lymphoblastic leukemia (ALL) cells. Both anti-CD19 and LMW-BCGF stimulated in vitro colony formation by ALL cells and showed additive effects when used together. [Ca2+]i responses to LMW-BCGF or CD19 cross-linking were also evident on certain pre-B-cell and lymphoma B-cell lines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450350      PMCID: PMC279888          DOI: 10.1073/pnas.85.6.1897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.

Authors:  A Pezzutto; B Dörken; P S Rabinovitch; J A Ledbetter; G Moldenhauer; E A Clark
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

2.  Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes.

Authors:  J Gordon; M Rowe; L Walker; G Guy
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

3.  B lymphocyte receptors and polyphosphoinositide degradation.

Authors:  M K Bijsterbosch; C J Meade; G A Turner; G G Klaus
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

4.  Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies.

Authors:  D E Yelton; C Desaymard; M D Scharff
Journal:  Hybridoma       Date:  1981

5.  The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen.

Authors:  P E Lipsky; P A Thompson; L J Rosenwasser; C A Dinarello
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

6.  Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients.

Authors:  F M Uckun; J H Kersey; K J Gajl-Peczalska; N A Heerema; A J Provisor; D Haag; G Gilchrist; C W Song; D C Arthur; J Roloff
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  The epidermal growth factor-induced calcium signal in A431 cells.

Authors:  W H Moolenaar; R J Aerts; L G Tertoolen; S W de Laat
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

8.  Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins.

Authors:  F M Uckun; W Jaszcz; J L Ambrus; A S Fauci; K Gajl-Peczalska; C W Song; M R Wick; D E Myers; K Waddick; J A Ledbetter
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

9.  Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes.

Authors:  T Pozzan; P Arslan; R Y Tsien; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  15 in total

1.  The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.

Authors:  Z Kozmik; S Wang; P Dörfler; B Adams; M Busslinger
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins.

Authors:  Thomas Oellerich; Mads Grønborg; Konstantin Neumann; He-Hsuan Hsiao; Henning Urlaub; Jürgen Wienands
Journal:  Mol Cell Proteomics       Date:  2009-04-16       Impact factor: 5.911

3.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Immunobiologic differences between normal and leukemic human B-cell precursors.

Authors:  F M Uckun; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Mitogenic stimulation of human B lymphocytes via the inositol phospholipid 'dual pathway' of signalling requires persistent activation of both second messenger arms.

Authors:  J Gordon; G R Guy; M J Millsum
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

6.  Differential responsiveness of human B lymphocytes to phorbol ester and calcium ionophore based on their state of activation.

Authors:  J Inglés; P Engel; O De La Calle; T Gallart
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

7.  Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms.

Authors:  S H Smith; K P Rigley; R E Callard
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

8.  Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.

Authors:  C L Miller; R Longnecker; E Kieff
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  The gene coding for the B cell surface protein CD19 is localized on human chromosome 16p11.

Authors:  P Stapleton; Z Kozmik; A Weith; M Busslinger
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

10.  Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.

Authors:  F M Uckun; A S Fauci; M Chandan-Langlie; D E Myers; J L Ambrus
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.